Esophageal Dysphagia Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 | Nestle Health Science S.A., Novartis AG, Fresenius Kabi AG, Abbott Laboratories, Danone S.A.

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Esophageal Dysphagia Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The esophageal dysphagia market size has grown strongly in recent years. It will grow from $1.96 billion in 2023 to $2.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to aging population, gastroesophageal reflux disease (gerd), advances in endoscopy, esophageal motility testing.

The esophageal dysphagia market size is expected to see strong growth in the next few years. It will grow to $2.67 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to obesity epidemic, minimally invasive procedures, personalized medicine, global expansion of esophageal dysphagia care. Major trends in the forecast period include patient-centered care, telehealth and remote monitoring, nutritional support, research collaboration.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13036&type=smp

Market Segmentation:
The main treatments of esophageal dysphagia are esophageal dilation, surgery, stent placement, laparoscopic heller myotomy, medications and lifestyle changes. Esophageal dilation refers to a medical procedure performed to widen a narrowed or constricted portion of the esophagus and is used to manage esophageal dysphagia caused by esophageal strictures. It can be diagnosed with dynamic swallowing study, X-ray, endoscope, manometry, imaging scans, magnetic resonance imaging (MRI) scan and computed tomography (CT) scans, with end-users as hospitals and clinics, ambulatory surgical centers, diagnostic centers, research centers and others.

Major Driver - Rising Smoking Rates Fueling Growth In The Esophageal Dysphagia Market
The growing number of smokers is expected to propel the growth of the esophageal dysphagia market going forward. Smokers typically refer to individuals who engage in the habit of smoking tobacco products, such as cigarettes, cigars, or pipes. Esophageal dysphagia can be exacerbated by smoking, which can lead to various health complications, including irritation and damage to the esophagus. The treatment for esophageal dysphagia helps patients suffering from the disease with enhanced nutrition and hydration, reduced risk of aspiration and improved quality of life. For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. Additionally, the total number of cigarettes sold rose 1.3% from May 2022, reaching 1.4 billion in June 2022. As a result, the growing number of smokers is driving the esophageal dysphagia market.

Competitive Landscape:
Major players in the esophageal dysphagia market are Nestle Health Science S.A., Novartis AG, Fresenius Kabi AG, Abbott Laboratories, Danone S.A., F. Hoffmann-La Roche Ltd., Merck Sharp and Dohme Corp., Pfizer Inc., Ingredion Incorporated, Eikonix Ltd., Olympus Corporation, Eisai Co. Ltd., Aurobindo Pharma Ltd., Dr. Reddys Laboratories, Cook Medical Incorporated, Elekta AB, Johnson and Johnson Ltd., C.R. Bard Inc., Avanos Medical Inc., Cipla Ltd., Kent Precision Foods Group Inc., Nutricia Ltd., CP Kelco Inc., Atos Medical AB, AstraZeneca PLC, NinePoint Medical Inc., Torax Medical Inc., Hormel Health Labs Inc., Dysphagia Management Systems LLC, Biostage Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/esophageal-dysphagia-global-market-report

Top Trend - Innovative Technologies Revolutionizing Esophageal Dysphagia Treatment
Major companies operating in the esophageal dysphagia market are developing innovative products with advanced technologies, such as pharyngeal electrical stimulation (PES) technology, to strengthen their relationship with current customers. Pharyngeal electrical stimulation (PES) technology is a therapeutic approach to address certain swallowing disorders, specifically dysphagia (difficulty swallowing), that arise from neurological conditions or other related factors. For instance, in October 2022, Phagenesis Ltd., a UK-based dysphagia care company, launched the Phagenyx neurostimulation system based on pharyngeal electrical stimulation technology. The phagenyx neurostimulation system is a novel rehabilitation treatment for dysphagia post-stroke by improving swallowing performance in patients with neurogenic dysphagia (ND) associated with stroke. It works by directly stimulating the pharynx using location-specific intraluminal catheters introduced trans nasally. Additionally, PES technology has the potential to improve the quality of life of patients with dysphagia, reduce healthcare costs and widen its application to a broader range of patients with dysphagia.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Esophageal Dysphagia Market Characteristics
3. Esophageal Dysphagia Market Trends And Strategies
4. Esophageal Dysphagia Market - Macro Economic Scenario
5. Esophageal Dysphagia Market Size And Growth
…..
27. Esophageal Dysphagia Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.